BofA/Merrill Lynch Downgrades Hospira (HSP) to Neutral
Tweet Send to a FriendGet Alerts HSP Hot Sheet
Price: $36.22 +0.84%
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 26 | New: 12
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 26 | New: 12
Trade HSP Now!
Intra-day, BofA/Merrill Lynch downgraded Hospira (NYSE: HSP) from Buy to Neutral following Q4 results.
For an analyst ratings summary and ratings history on Hospira click here. For more ratings news on Hospira click here.
Shares of Hospira closed at $34.95 yesterday, with a 52 week range of $28.62-$38.49.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Hospira click here. For more ratings news on Hospira click here.
Shares of Hospira closed at $34.95 yesterday, with a 52 week range of $28.62-$38.49.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- UPDATE: Exane BNP Paribas Downgrades BlackBerry (BBRY) to Underperform; Analyst Says Profit 'Drying Up'
- Goldman Sachs Downgrades InterXion Holding (INXN) to Neutral
Create E-mail Alert Related Categories
Analyst EPS View, DowngradesRelated Entities
Merrill Lynch, Bank of America
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
